Functional plasticity of the human infant β-cell exocytotic phenotype

Endocrinology

Volumn 154, Issue 4, 2013, Pages 1392-1399

  Fox, Jocelyn E Manning ^a   Seeberger, Karen ^a   Dai, Xiao Qing ^a   Lyon, James ^a   Spigelman, Aliya F ^a   Kolic, Jelena ^a   Hajmrle, Catherine ^a   Joseph, Jamie W ^b   Kin, Tatsuya ^a   Shapiro, A M James ^a   Korbutt, Gregory ^a   MacDonald, Patrick E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 1; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.1; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN 1A; TRANSCRIPTION FACTOR PDX 1;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL MATURATION; CELL STRUCTURE; CONTROLLED STUDY; EXOCYTOSIS; HUMAN; HUMAN CELL; INFANT; INSULIN RELEASE; PANCREAS BIOPSY; PANCREAS ISLET BETA CELL; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CALCIUM CHANNELS, L-TYPE; CELL DIFFERENTIATION; CELLS, CULTURED; EXOCYTOSIS; FEMALE; GLUCAGON; GLUCOSE TRANSPORTER TYPE 1; HUMANS; INFANT; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PATCH-CLAMP TECHNIQUES; PHENOTYPE; POTASSIUM CHANNELS, INWARDLY RECTIFYING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; SYNTAXIN 1;

EID: 84875853629     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1934     Document Type: Article

References (39)

1. Jermendy A, Toschi E, Aye T, et al. Rat neonatal β cells lack the specialised metabolic phenotype of mature β cells. Diabetologia. 2011;54:594-604.
2. Grill V, Asplund K, Hellerstrom C, Cerasi E. Decreased cyclic AMP and insulin response to glucose in isolated islets of neonatal rats. Diabetes. 1975;24:746-752.
3. Grasso S, Messina A, Saporito N, Reitano G. Serum-insulin response to glucose and aminoacids in the premature infant. Lancet. 1968; 2:755-756.
4. Bliss CR, Sharp GW. Glucose-induced insulin release in islets of young rats: time-dependent potentiation and effects of 2-bromostearate. Am J Physiol. 1992;263:E890-E896.
5. De Leon DD, Stanley CA. Mechanisms of disease: advances in diagnosis and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol Metab. 2007;3:57-68.
6. Rubio-Cabezas O, Klupa T, Malecki MT. Permanent neonatal diabetes mellitus-the importance of diabetes differential diagnosis in neonates and infants. Eur J Clin Invest. 2011;41:323-333.
7. Ashcroft FM. New uses for old drugs: neonatal diabetes and sulphonylureas. Cell Metab. 2010;11:179-181.
8. Saisho Y, Butler AE, Manesso E, Elashoff D, Rizza RA, Butler PC. β-Cell mass and turnover in humans: effects of obesity and aging. Diabetes Care. 2013;36(1):111-117.
9. Rieck S, Kaestner KH. Expansion of β-cell mass in response to pregnancy. Trends Endocrinol Metab. 2010;21:151-158.
10. Lefebvre VH, Otonkoski T, Ustinov J, Huotari MA, Pipeleers DG, Bouwens L. Culture of adult human islet preparations with hepatocyte growth factor and 804G matrix is mitogenic for duct cells but not for β-cells. Diabetes. 1998;47:134-137.
11. Parnaud G, Bosco D, Berney T, et al. Proliferation of sorted human and rat β cells. Diabetologia. 2008;51:91-100.
12. Meier JJ, Butler AE, Saisho Y, et al. β-Cell replication is the primary mechanism subserving the postnatal expansion of β-cell mass in humans. Diabetes. 2008;57:1584-1594.
13. Kin T, Korbutt GS, Kobayashi T, Dufour JM, Rajotte RV. Reversal of diabetes in pancreatectomized pigs after transplantation of neonatal porcine islets. Diabetes. 2005;54:1032-1039.
14. Cardona K, Korbutt GS, Milas Z, et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med. 2006;12:304-306.
15. MacDonald PE, Joseph JW, Rorsman P. Glucose-sensing mechanisms in pancreatic β-cells. Philos Trans R Soc Lond B Biol Sci. 2005;360:2211-2225.
16. Korbutt GS, Elliott JF, Ao Z, Smith DK, Warnock GL, Rajotte RV. Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest. 1996;97:2119-2129.
17. Kin T, Shapiro AM. Surgical aspects of human islet isolation. Islets. 2010;2:265-273.
18. Dai XQ, Plummer G, Casimir M, et al. SUMOylation regulates insulin exocytosis downstream of secretory granule docking in rodents and humans. Diabetes. 2011;60:838-847.
19. Seeberger KL, Dufour JM, Shapiro AM, Lakey JR, Rajotte RV, Korbutt GS. Expansion of mesenchymal stem cells from human pancreatic ductal epithelium. Lab Invest. 2006;86:141-153.
20. Seeberger KL, Eshpeter A, Rajotte RV, Korbutt GS. Epithelial cells within the human pancreas do not coexpress mesenchymal antigens: epithelial- mesenchymal transition is an artifact of cell culture. Lab Invest. 2009;89:110-121.
21. McCulloch LJ, van de Bunt M, Braun M, Frayn KN, Clark A, Gloyn AL. GLUT2 (SLC2A2) is not the principal glucose transporter in human pancreatic β cells: implications for understanding genetic association signals at this locus. Mol Genet Metab. 2011;104:648-653.
22. + channel subunit Kir6.2 in mouse pancreas. Diabetes. 1997;46:1440-1444.
23. + ATP channels in human pancreatic β cells early in development. Diabetologia. 2007;50:1000-1005.
24. Grasso S, Messina A, Distefano G, Vigo R, Reitano G. Insulin secretion in the premature infant. Response to glucose and amino acids. Diabetes. 1973;22:349-353.
25. Falorni A, Fracassini F, Massi-Benedetti F, Maffei S. Glucose metabolism and insulin secretion in the newborn infant. Comparisons between the responses observed the first and seventh day of life to intravenous and oral glucose tolerance tests. Diabetes. 1974;23: 172-178.
26. Zung A, Glaser B, Nimri R, Zadik Z. Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J Clin Endocrinol Metab. 2004;89:5504-5507.
27. Kryskoa DV, Vanden Berghea T, D'Herdec K, Vandenabeele P. Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods. 2008;44:205-221.
28. Hanley SC, Pilotte A, Massie B, Rosenberg L. Cellular origins of adult human islet in vitro dedifferentiation. Lab Invest. 2008;88: 761-772.
29. Russ HA, Sintov E, Anker-Kitai L, Friedman O, et al. Insulin-producing cells generated from dedifferentiated human pancreatic β cells expanded in vitro. PLoS One. 2011;6:e25566.
30. Russ HA, Bar Y, Ravassard P, Efrat S. In vitro proliferation of cells derived from adult human β-cells revealed by cell-lineage tracing. Diabetes. 2008;57:1575-1583.
31. Henquin JC, Nenquin M, Sempoux C, et al. In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions. J Clin Invest. 2011;121:3932-3942.
32. Alejandro EU, Kalynyak TB, Taghizadeh F, et al. Acute insulin signaling in pancreatic β-cells is mediated by multiple Raf-1 dependent pathways. Endocrinology. 2010;151:502-512.
33. Johnson JD, Alejandro EU. Control of pancreatic β-cell fate by insulin signaling: the sweet spot hypothesis. Cell Cycle. 2008;7:1343-1347.
34. Johnson JD, Bernal-Mizrachi E, Alejandro EU, et al. Insulin protects islets from apoptosis via Pdx1 and specific changes in thehumanislet proteome. Proc Natl Acad Sci USA. 2006;103:19575-19580.
35. Okada T, Liew CW, Hu J, et al. Insulin receptors in β-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci USA. 2007;104:8977-8982.
36. 2+-induced exocytosis in mouse pancreatic B-cells. J Physiol. 1997;503(pt 2):399-412.
37. Ivarsson R, Quintens R, Dejonghe S, et al. Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes. 2005;54:2132-2142.
38. Vegari E, Plummer G, Dai X, MacDonald PE. DeSUMOylation controls insulin exocytosis in response to metabolic signals. Biomolecules. 2012;2:269-281.
39. Bliss CR, Sharp GW. Glucose-induced time-dependent potentiation and "run down" of insulin secretion in islets of young rats. Adv Exp Med Biol. 1997;426:21-26.